Showing results (11-20 of 624) with videos related to

Sort By:
Pageof 63
Haematologica|June 22, 2001
Ten-year follow-up of a single center prospective trial of unmanipulated peripheral blood stem cell autograft and interferon-alpha in early phase chronic myeloyd leukemiaG Meloni, S Capria, M Vignetti, et al.
Haematologica|September 12, 2000
Unmanipulated peripheral blood stem cell autograft in chronic lymphocytic leukemia: clinical findings and biological monitoringG Meloni, A Proia, F Mauro, et al.
Blood|August 1, 1997
Autologous bone marrow transplantation for acute promyelocytic leukemia in second remission: prognostic relevance of pretransplant minimal residual disease assessment by reverse-transcription polymerase chain reaction of the PML/RAR alpha fusion geneG Meloni, D Diverio, M Vignetti, et al.
Annals of Hematology|March 31, 2000
Conventional salvage chemotherapy vs. high-dose therapy with autografting for recurrent or refractory Hodgkin's disease patientsA P Anselmo, G Meloni, E Cavalieri, et al.
Mediterranean Journal of Hematology and Infectious Diseases|August 13, 2013
Complete remission obtained with azacitidine in a patient with concomitant therapy related myeloid neoplasm and pulmonary mucormycosisS Capria, F De Angelis, G Gentile, et al.
Annals of Hematology|April 27, 2002
Thrombotic thrombocytopenic purpura and pregnancy: a case report and a review of the literatureA Proia, R Paesano, F Torcia, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 6, 2001
Acute myeloid leukemia and lung cancer occurring in a chronic lymphocytic leukemia patient treated with fludarabine and autologous peripheral blood stem-cell transplantationG Meloni, A Proia, V Guerrisi, et al.
Blood|June 15, 1990
BAVC regimen and autologous bone marrow transplantation in patients with acute myelogenous leukemia in second remissionG Meloni, P De Fabritiis, M C Petti, et al.
Leukemia|November 1, 1992
Has IL2 a role in the management of minimal residual disease for acute leukemia?R Foa, G Meloni, A Guarini, et al.
Haematologica|July 1, 1996
Lack of efficacy of a double autograft program to prolong survival of chronic myelogenous leukemia patients in blastic transformationS Capria, M Vignetti, E Montefusco, et al.
Pageof 63